Document is current
Any future updates will be listed below
-
Authors
Suematsu, Yu
Nagoshi, Narihito
Shinozaki, Munehisa
Kase, Yoshitaka
Saijo, Yusuke
Hashimoto, Shogo
Shibata, Takahiro
Kajikawa, Keita
Kamata, Yasuhiro
Ozaki, Masahiro
Yasutake, Kaori
Shindo, Tomoko
Shibata, Shinsuke
Matsumoto, Morio
Nakamura, Masaya
Okano, Hideyuki https://orcid.org/0000-0001-7482-5935
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP23ym0126118, JP15bm0204001q)
Japan Society for the Promotion of Science (22H03205, 17H06312)
Orthopedic Research and Education Foundation
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 18 September 2023
First Online: 16 October 2023
Declarations
:
: All experimental procedures were approved by the ethics committee of KeioUniversity and were performed in accordance with the Guide for the Care and Use of Laboratory Animals (U.S. National Institutes of Health).
: Not applicable.
: A patent application is currently pending for combined therapy of HGF and hiPSC-NS/PC transplantation for subacute spinal cord injury (09/08/2023, PCT/JP2023/32768) and YS, NN, MN, and HO are listed as an inventor on the patent.
